India progresses in GM rice development
Some 13 lines of genetically modified rice are in various stages of testing and development in India, reveals the country’s Ministry of Environment. They include five insect-resistant, one disease-resistant and seven output trait lines. The insect-resistant lines include: three containing the Bt cry1Ac toxin from Monsanto’s Indian joint venture partner, Mahyco, Bayer CropScience and the Indian Institute of Agricultural Research (IARI); one from the IARI containing the cry1Aa3 toxin; and a line from DuPont seed subsidiary Pioneer Hi-Bred International. The IARI is also developing a disease-resistant line expressing a chitinase gene. Field trials are being conducted by Mahyco and Bayer, while the other lines are still in earlier stages of development.